Empowering Patients & Accelerating Personalized Medicine R&D; Biological/Clinical Data
Sanguine is a technology-enabled company innovating at the intersection of personalized medicine, biobanking, and biomedical research. It has a simple and attractive, proven business model. Sanguine collects blood samples and associated medical data from patients diagnosed with specific conditions. It processes those samples to extract biospecimen such as cells, serum, plasma and DNA, and stores them along with the medical data. It then sells the biospecimen and data to academic and pharmaceutical entities for research purposes.
Problem & Solution:
Traditionally, research companies need to wait for physicians to set up appointments with patients and to find some willing to sign up. Patients go to Sanguine because Sanguine offers increased transparency in the research process, showing them where samples are used and how they advance biomedical research in areas they care about.
Sanguine has developed a technology that efficiently deploys per diem nurses to perform blood donations at patients' homes that are interested in donating blood to Sanguine and to biomedical research.
Sanguine has >200 pharmaceutical and biotechnology clients, including 20 of the top 50 Fortune 500 Pharmas. We can not share this information publicly, but if there is an interest to invest, we can certainly provide you with copies of Purchase Orders and invoices in a private message.